ERBB2 and breast carcinoma: Breast cancers expressing human epidermal growth factor receptor 2 (HER2) have a higher propensity to metastasize to the central nervous system (CNS) compared to hormone receptor (HR)-positive/HER2-negative disease subtypes4,5